China-based gene sequencing specialist MGI Tech Co., Ltd (SHA: 688114) has entered into a strategic partnership with Sabin Group, one of the largest diagnostic laboratories in Brazil. This collaboration aims to enhance the accessibility and quality of genetic sequencing services, thereby improving the healthcare standards for the Brazilian population. Financial details of the agreement have not been disclosed.
Sabin’s Advanced Genetic Sequencing Capabilities
Sabin Group is equipped with the DNBSEQ-G400 genomic sequencer, a cutting-edge technology that facilitates large and medium-scale sequencing. Additionally, Sabin utilizes the MGISP-100, an automated library preparation system developed by MGI for high-throughput DNA sequencing. The implementation of the DNBSEQ-G400 has led to a remarkable 78% increase in sample size, significantly bolstering Sabin’s capacity to offer comprehensive diagnostic services to patients.
MGISP-100: Enhancing Laboratory Efficiency and Cost-Effectiveness
The MGISP-100 system, when used in conjunction with the DNBSEQ-G400, allows for batch processing of samples, reducing the need for repetitive manual operations by laboratory personnel. This not only improves the stability of library preparation but also leads to a reduction in overall costs, thereby enhancing the operational efficiency of the laboratory. The partnership between MGI Tech and Sabin Group is set to transform the landscape of genetic sequencing and diagnostic services in Brazil.-Fineline Info & Tech
